These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16839653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H, Iyo M, Hashimoto K.
    Brain Res; 2009 Dec 08; 1301():189-96. PubMed ID: 19748494
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
    Zhang L, Shirayama Y, Shimizu E, Iyo M, Hashimoto K.
    Eur J Pharmacol; 2006 Aug 21; 544(1-3):1-9. PubMed ID: 16859675
    [Abstract] [Full Text] [Related]

  • 7. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y, Nakamura S, Uda M, Kajii Y, Abe M, Baba A, Matsuda T.
    Neuropharmacology; 2006 Sep 21; 51(4):914-22. PubMed ID: 16863654
    [Abstract] [Full Text] [Related]

  • 8. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH, Shen YC, Wang YH, Chi CW, Yen JC.
    Toxicology; 2006 Sep 21; 226(2-3):238-45. PubMed ID: 16887252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL, Itzhak Y.
    Ann N Y Acad Sci; 2006 Aug 21; 1074():225-33. PubMed ID: 17105919
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.
    Hozumi H, Asanuma M, Miyazaki I, Fukuoka S, Kikkawa Y, Kimoto N, Kitamura Y, Sendo T, Kita T, Gomita Y.
    Toxicol Lett; 2008 Mar 15; 177(2):123-9. PubMed ID: 18282668
    [Abstract] [Full Text] [Related]

  • 16. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
    Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A, Matsuda T.
    Synapse; 2007 Sep 15; 61(9):757-63. PubMed ID: 17568413
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
    Itzhak Y, Anderson KL, Ali SF.
    Ann N Y Acad Sci; 2004 Oct 15; 1025():119-28. PubMed ID: 15542708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.